Disclosed herein are compounds, compositions and methods related to viral inhibition. In some forms, the compounds, compositions and methods are related to binding RNA
WSU inventor: William C. Groutas, Dept. of Chemistry, College of Liberal Arts and SciencesAppl. no.:...
© Springer Nature Singapore Pte Ltd. 2017. Emerging variants of known RNA viruses present an increas...
Imminent threat of pandemics of influenza, along with increasing resistance of the virus to existing...
Disclosed herein are compounds, compositions and methods related to viral inhibition. In some forms,...
The present invention relates to the use of compounds of formula (I) as inhibitors of RNA guided end...
There are virtually no antiviral drugs available for the treatment of infections with RNA viruses. T...
RNA-dependent RNA polymerase (RdRP) is essential for the replication and expression of RNA viral gen...
Antiviral Drug Discovery is still a great challenge due to the virus's ability to mutate in order to...
This disclosure relates to methods and compositions for managing vascular conditions by targeting mi...
The subject invention provides a novel and advantageous method for preventing and treating viral inf...
SummaryThere are no approved therapeutics for the most deadly nonsegmented negative-strand (NNS) RNA...
The advent of gene silencing siRNA technology has created opportunities to develop therapeutics base...
Raw data of the paper titled "Inhibition of cellular RNA methyltransferase abrogates influenza virus...
This PhD thesis is dedicated to the development of novel antiviral agents against Chikungunya virus ...
Our recent efforts have been directed at the development of selective inhibitors of different classe...
WSU inventor: William C. Groutas, Dept. of Chemistry, College of Liberal Arts and SciencesAppl. no.:...
© Springer Nature Singapore Pte Ltd. 2017. Emerging variants of known RNA viruses present an increas...
Imminent threat of pandemics of influenza, along with increasing resistance of the virus to existing...
Disclosed herein are compounds, compositions and methods related to viral inhibition. In some forms,...
The present invention relates to the use of compounds of formula (I) as inhibitors of RNA guided end...
There are virtually no antiviral drugs available for the treatment of infections with RNA viruses. T...
RNA-dependent RNA polymerase (RdRP) is essential for the replication and expression of RNA viral gen...
Antiviral Drug Discovery is still a great challenge due to the virus's ability to mutate in order to...
This disclosure relates to methods and compositions for managing vascular conditions by targeting mi...
The subject invention provides a novel and advantageous method for preventing and treating viral inf...
SummaryThere are no approved therapeutics for the most deadly nonsegmented negative-strand (NNS) RNA...
The advent of gene silencing siRNA technology has created opportunities to develop therapeutics base...
Raw data of the paper titled "Inhibition of cellular RNA methyltransferase abrogates influenza virus...
This PhD thesis is dedicated to the development of novel antiviral agents against Chikungunya virus ...
Our recent efforts have been directed at the development of selective inhibitors of different classe...
WSU inventor: William C. Groutas, Dept. of Chemistry, College of Liberal Arts and SciencesAppl. no.:...
© Springer Nature Singapore Pte Ltd. 2017. Emerging variants of known RNA viruses present an increas...
Imminent threat of pandemics of influenza, along with increasing resistance of the virus to existing...